Format

Send to

Choose Destination
Neuropsychiatr Dis Treat. 2016 Apr 5;12:763-75. doi: 10.2147/NDT.S98367. eCollection 2016.

Parkinson's disease managing reversible neurodegeneration.

Author information

1
Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, USA.
2
Stein Orthopedic Associates, Plantation, FL, USA.
3
Cole Center for Healing, Cincinnati, OH, USA.
4
CLEARCenter of Health, Mill Valley, CA, USA.
5
Four Pillars Health, Brendale, QLD, Australia.

Abstract

Traditionally, the Parkinson's disease (PD) symptom course has been classified as an irreversible progressive neurodegenerative disease. This paper documents 29 PD and treatment-induced systemic depletion etiologies which cause and/or exacerbate the seven novel primary relative nutritional deficiencies associated with PD. These reversible relative nutritional deficiencies (RNDs) may facilitate and accelerate irreversible progressive neurodegeneration, while other reversible RNDs may induce previously undocumented reversible pseudo-neurodegeneration that is hiding in plain sight since the symptoms are identical to the symptoms being experienced by the PD patient. Documented herein is a novel nutritional approach for reversible processes management which may slow or halt irreversible progressive neurodegenerative disease and correct reversible RNDs whose symptoms are identical to the patient's PD symptoms.

KEYWORDS:

B6; L-dopa; Parkinson’s disease; carbidopa; neurodegeneration

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center